2m 2m 2m 2m 2m 2m 2m
SERA PROGNSTCS-A (SERA)
NASDAQ
$2.08+$0.03 (+1.22%)
Price as of Jun 03, 2026 4:10 PM EDT- $82.5MMarket Cap
- 20.59%1-Year Change
- Medical DevicesIndustry
SERA PROGNSTCS-A (SERA)
$2.08+$0.03 (+1.22%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 81,000 +5.19% | 77,000 -74.84% | 306,000 +14.18% | 268,000 +226.83% | |
Cost of Revenue | 164,000 +100.00% | 82,000 N/A | N/A N/A | N/A N/A | |
Gross Profit | -83,000 +1,560.00% | -5,000 -101.63% | 306,000 +14.18% | 268,000 +226.83% | |
Sales and Marketing Expense | 6.5M +13.46% | 5.8M -30.88% | 8.3M -43.20% | 14.7M +42.32% | |
Research and Development Expense | -13.2M -10.58% | -14.7M -3.25% | -15.2M +6.89% | -14.2M +29.27% | |
Depreciation and Amortization Expense | 940,000 +12.85% | 833,000 -7.44% | 900,000 +19.05% | 756,000 +14.72% | |
Total Operating Expenses | 36.6M -0.35% | 36.7M -8.51% | 40.1M -12.62% | 45.9M +29.44% | |
Operating Profit | -36.5M -0.36% | -36.6M -8.00% | -39.8M -12.77% | -45.7M +28.98% | |
Interest Income | 4.3M +54.82% | 2.7M +67.50% | 1.6M +259.65% | 456,000 +214.48% | |
Interest Expense | -9,000 -67.86% | -28,000 N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 4.2M +56.09% | 2.7M +65.79% | 1.6M +259.65% | 456,000 +278.82% | |
Total Nonoperating Income and Expense | 4.6M +21.78% | 3.8M +3.60% | 3.6M +137.98% | 1.5M +34.89% | |
Income before Taxes | -36.5M -0.36% | -36.6M -8.00% | -39.8M -12.77% | -45.7M +28.98% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -31.9M -2.95% | -32.9M -9.23% | -36.2M -17.98% | -44.2M +26.21% | |
Net Income from Continuing Operations Applicable to Common | -31.9M -2.95% | -32.9M -9.23% | -36.2M -17.98% | -44.2M +26.21% | |
Basic EPS and Net Income | -0.67 -32.32% | -0.99 -14.66% | -1.16 -18.88% | -1.43 -38.63% | |
Diluted EPS and Net Income | -0.67 -32.32% | -0.99 -14.66% | -1.16 -18.88% | -1.43 -38.63% | |
Basic Weighted Average Shares | 47.7M +43.75% | 33.2M +6.27% | 31.2M +0.83% | 30.9M +106.25% | |
Diluted Weighted Average Shares | 47.7M +43.75% | 33.2M +6.27% | 31.2M +0.83% | 30.9M +106.25% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.9M -2.45% | 4.0M +4.20% | 3.9M -87.01% | 29.9M -49.30% | |
Short-Term Investments | 35.3M -16.44% | 42.2M -6.65% | 45.2M -14.44% | 52.8M +14.38% | |
Cash and Cash Equivalents and Short-Term Investments | 39.2M -15.22% | 46.2M -5.79% | 49.1M -40.66% | 82.7M -21.32% | |
Total Current Assets | 40.8M -14.35% | 47.6M -22.40% | 61.3M -31.93% | 90.1M -18.25% | |
Accumulated Depreciation | 8.5M +9.84% | 7.8M +10.45% | 7.0M +12.24% | 6.3M +4.84% | |
Property and Plant and Equipment and Net | 1.1M -7.26% | 1.2M -38.02% | 2.0M -34.65% | 3.1M +72.53% | |
Total Long-Term Assets | 2.5M +242.61% | 737,000 -41.37% | 1.3M -30.78% | 1.8M +1,056.69% | |
Total Assets | 101.9M +40.45% | 72.6M -23.96% | 95.4M -17.96% | 116.3M -20.88% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 24.2M -2.35% | 24.8M +1.34% | 24.4M +57.31% | 15.5M +84.73% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 10.0M N/A | |
Total Long-Term Liabilities | 2.3M N/A | 0 -100.00% | 644,000 -47.30% | 1.2M N/A | |
Total Liabilities | 26.5M +7.08% | 24.8M -2.02% | 25.3M +45.42% | 17.4M +105.39% | |
Retained Earnings | -311.7M +11.41% | -279.8M +13.32% | -246.9M +17.20% | -210.7M +26.54% | |
Total Stockholders Equity | 75.4M +57.75% | 47.8M -31.86% | 70.2M -29.09% | 98.9M -28.59% | |
Total Shares Outstanding | 38.0M +14.36% | 33.2M +4.74% | 31.7M +2.21% | 31.0M +0.79% | |
Cash Flow | |||||
Cash from Operating Activities | -25.6M +80.58% | -14.2M -47.81% | -27.2M -21.44% | -34.6M +9.40% | |
Capital Expenditures | 726,000 +1,196.43% | 56,000 -56.25% | 128,000 -83.82% | 791,000 -39.34% | |
Cash from Investing Activities | -28.5M -342.71% | 11.7M +2,581.05% | 438,000 -92.11% | 5.6M +106.72% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 54.0M +1,970.76% | 2.6M +246.94% | 752,000 +14,940.00% | 5,000 -100.00% | |
Financials Ratio | |||||
Gross Margin | -102.47% +1,478.03% | -6.49% N/A | N/A N/A | N/A N/A | |
Operating Margin | -45,066.67% -5.28% | -47,577.92% +265.61% | -13,013.40% -23.60% | -17,034.33% N/A | |
Return on Assets | -36.59% -6.56% | -39.16% +14.41% | -34.23% +2.00% | -33.56% N/A | |
Return on Equity | -51.83% -7.08% | -55.78% +30.13% | -42.86% +15.20% | -37.21% N/A | |
Revenue Growth | 5.19% +106.94% | -74.84% -627.80% | 14.18% -93.75% | 226.83% N/A | |
Current Ratio | 1.69 -12.29% | 1.92 -23.43% | 2.51 -56.73% | 5.80 N/A | |
Cash Ratio | 0.16 -0.06% | 0.16 +2.84% | 0.16 -91.75% | 1.92 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow